JP2004516236A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004516236A5 JP2004516236A5 JP2001583806A JP2001583806A JP2004516236A5 JP 2004516236 A5 JP2004516236 A5 JP 2004516236A5 JP 2001583806 A JP2001583806 A JP 2001583806A JP 2001583806 A JP2001583806 A JP 2001583806A JP 2004516236 A5 JP2004516236 A5 JP 2004516236A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibody
- composition according
- factor
- antibody fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57143400A | 2000-05-15 | 2000-05-15 | |
| PCT/US2000/027438 WO2001087339A1 (en) | 2000-05-15 | 2000-10-05 | Antithrombotic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004516236A JP2004516236A (ja) | 2004-06-03 |
| JP2004516236A5 true JP2004516236A5 (enExample) | 2007-11-22 |
Family
ID=24283688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001583806A Pending JP2004516236A (ja) | 2000-05-15 | 2000-10-05 | 抗血栓剤 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20050037006A1 (enExample) |
| EP (2) | EP1825864A3 (enExample) |
| JP (1) | JP2004516236A (enExample) |
| KR (2) | KR20030034071A (enExample) |
| CN (2) | CN101134107A (enExample) |
| AT (1) | ATE345816T1 (enExample) |
| AU (2) | AU7858400A (enExample) |
| BR (1) | BR0015872A (enExample) |
| CA (1) | CA2411369A1 (enExample) |
| CZ (1) | CZ20023778A3 (enExample) |
| DE (1) | DE60032029T2 (enExample) |
| ES (1) | ES2277597T3 (enExample) |
| HU (1) | HU225874B1 (enExample) |
| IL (1) | IL152831A0 (enExample) |
| MX (1) | MXPA02011385A (enExample) |
| NO (1) | NO20025463L (enExample) |
| NZ (1) | NZ522632A (enExample) |
| PL (1) | PL360060A1 (enExample) |
| WO (1) | WO2001087339A1 (enExample) |
| ZA (1) | ZA200209265B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2807274T3 (es) | 2002-03-20 | 2021-02-22 | Univ Maryland | Un canal catiónico no selectivo en células neurales y compuestos que bloquean el canal para su uso en el tratamiento de la inflamación del cerebro |
| US8980952B2 (en) | 2002-03-20 | 2015-03-17 | University Of Maryland, Baltimore | Methods for treating brain swelling with a compound that blocks a non-selective cation channel |
| US10583094B2 (en) | 2004-09-18 | 2020-03-10 | University Of Maryland | Therapeutic methods that target the NCCA-ATP channel |
| JP5085326B2 (ja) | 2004-09-18 | 2012-11-28 | ユニバーシティ オブ メリーランド，ボルチモア | ＮＣＣａ−ＡＴＰチャネルを標的とする処置剤およびその使用方法 |
| WO2008089103A2 (en) | 2007-01-12 | 2008-07-24 | University Of Maryland, Baltimore | Targeting ncca-atp channel for organ protection following ischemic episode |
| CA2691199C (en) | 2007-06-22 | 2017-09-12 | Marc J. Simard | Inhibitors of ncca-atp channels for therapy |
| EP3127921A1 (en) | 2007-09-26 | 2017-02-08 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substition in cdr |
| CA2705851C (en) * | 2007-11-21 | 2016-11-01 | Oregon Health & Science University | Anti-factor xi monoclonal antibodies and methods of use thereof |
| GB201121513D0 (en) * | 2011-12-14 | 2012-01-25 | Cambridge Entpr Ltd | Thrombin-binding antibody molecules and uses thereof |
| US9518128B2 (en) | 2011-12-14 | 2016-12-13 | Janssen Pharmaceuticals, Inc. | Thrombin-binding antibody molecules |
| CN118320078A (zh) * | 2016-12-23 | 2024-07-12 | 诺华股份有限公司 | 采用抗因子XI/XIa抗体治疗的方法 |
| US20200109390A1 (en) | 2017-04-27 | 2020-04-09 | Chugai Seiyaku Kabushiki Kaisha | Coagulation factor ix with improved pharmacokinetics |
| US20240018503A1 (en) * | 2017-04-27 | 2024-01-18 | Chugai Seiyaku Kabushiki Kaisha | Coagulation factor ix with improved pharmacokinetics |
| CN115448985A (zh) * | 2021-06-08 | 2022-12-09 | 上海循曜生物科技有限公司 | 新型抗栓抗体 |
| CN121758622B (zh) * | 2026-03-04 | 2026-07-24 | 上海快序生物科技有限公司 | 一种完全人源的抗人凝血因子ix单克隆抗体或其抗原结合片段及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2049655C (en) * | 1990-09-17 | 1996-11-12 | Akio Odawara | Pharmaceutical composition for inhibiting platelet aggregation |
| MA24512A1 (fr) * | 1996-01-17 | 1998-12-31 | Univ Vermont And State Agrienl | Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose |
| WO2000007626A1 (en) * | 1998-08-07 | 2000-02-17 | Smithkline Beecham Corporation | Use of anti-coagulation factor antibodies as long-lasting protective agents |
| ES2177316T3 (es) * | 1998-08-28 | 2002-12-01 | Genentech Inc | Anticuerpos humanos antifacotores ix/ixa. |
-
2000
- 2000-10-05 EP EP06124420A patent/EP1825864A3/en active Pending
- 2000-10-05 KR KR1020027015403A patent/KR20030034071A/ko not_active Ceased
- 2000-10-05 DE DE60032029T patent/DE60032029T2/de not_active Expired - Fee Related
- 2000-10-05 WO PCT/US2000/027438 patent/WO2001087339A1/en not_active Ceased
- 2000-10-05 AU AU7858400A patent/AU7858400A/xx active Pending
- 2000-10-05 ES ES00968710T patent/ES2277597T3/es not_active Expired - Lifetime
- 2000-10-05 HU HU0301804A patent/HU225874B1/hu not_active IP Right Cessation
- 2000-10-05 AU AU2000278584A patent/AU2000278584B2/en not_active Ceased
- 2000-10-05 NZ NZ522632A patent/NZ522632A/en unknown
- 2000-10-05 IL IL15283100A patent/IL152831A0/xx unknown
- 2000-10-05 MX MXPA02011385A patent/MXPA02011385A/es active IP Right Grant
- 2000-10-05 JP JP2001583806A patent/JP2004516236A/ja active Pending
- 2000-10-05 CN CNA200710141110XA patent/CN101134107A/zh active Pending
- 2000-10-05 CA CA002411369A patent/CA2411369A1/en not_active Abandoned
- 2000-10-05 CZ CZ20023778A patent/CZ20023778A3/cs unknown
- 2000-10-05 BR BR0015872-0A patent/BR0015872A/pt not_active IP Right Cessation
- 2000-10-05 AT AT00968710T patent/ATE345816T1/de not_active IP Right Cessation
- 2000-10-05 CN CNB008197237A patent/CN100339132C/zh not_active Expired - Fee Related
- 2000-10-05 PL PL36006000A patent/PL360060A1/xx unknown
- 2000-10-05 KR KR1020077027348A patent/KR20070116192A/ko not_active Ceased
- 2000-10-05 EP EP00968710A patent/EP1282444B1/en not_active Expired - Lifetime
-
2002
- 2002-11-14 ZA ZA200209265A patent/ZA200209265B/xx unknown
- 2002-11-14 NO NO20025463A patent/NO20025463L/no not_active Application Discontinuation
-
2003
- 2003-08-11 US US10/638,777 patent/US20050037006A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU92255I2 (fr) | Ocriplasmine et ses dérivés pharmaceutiquement acceptables (JETREA) | |
| Lijnen et al. | Fibrinolytic agents: mechanisms of activity and pharmacology | |
| DE60143393D1 (de) | Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür | |
| WO2002095007A3 (en) | Conjugates activated by cell surface proteases and therapeutic uses thereof | |
| MXPA04005755A (es) | Combinacion de inhibidores de proteasa dependientes del citocromo p450. | |
| WO2001070204A3 (de) | Hochselektive inhibitoren des urokinase-plasminogenaktivators | |
| WO2001068645A3 (en) | N-cyanomethylcarboxamides and their use as protease inhibitors | |
| EP1825864A3 (en) | Antithrombotic agents | |
| WO2003008637A3 (en) | Use of genotyping in the individualization of therapy | |
| PT1227797E (pt) | Formulacoes farmaceuticas de dispersao solida | |
| WO2002057246A3 (en) | Inhibitors of cruzipain and other cysteine proteases | |
| SE0000303D0 (sv) | Novel compounds | |
| WO2003053999A3 (de) | Selektive arylguanidinpeptide als urokinaseinhibitoren | |
| CA2007075A1 (en) | New thrombolytic compositions | |
| BRPI0317780B8 (pt) | uso de supositório de estreptoquinase com ação trombolítica | |
| AU2712799A (en) | The use of estradiol derivatives for treating side-effects during and/or after gnrha therapy | |
| Thomson | New thrombolytic drugs | |
| MY120631A (en) | Novel pharmaceutical combination having analgesic activity | |
| JP2001521898A5 (ja) | 心筋虚血およびアンギナの処置用医薬の製造のためのキナプリルの使用 |